<?xml version="1.0" encoding="UTF-8"?>
<p id="Par102">Texas Childrenâ€™s Hospital Center for Vaccine Development at Baylor College of Medicine has developed and tested a subunit vaccine which concludes only the receptor-binding domain (RBD) of the SARS-CoV S-protein. This vaccine elicits high levels of protective immunity on the homologous virus challenge. Also, it can minimize host Immuno potentiation [
 <xref ref-type="bibr" rid="CR106">106</xref>].
</p>
